// App-Quantinova.ai

Abstract WP173 : Interaction Between CYP2C19 Allele Status And Outcome Following Ischemic Stroke In Patients Treated With Clopidogrel: A TARDIS Trial Substudy

Researchers

Presenter

  • John H McDermott

Principal Investigators

  • Lisa J Woodhouse

  • Dwaipayan Sen

  • Craig J Smith

  • William G Newman

  • Philip M Bath

Medical Centers

  • The Div of Evolution, Infection and Genomics, UNIVERSITY OF MANCHESTER, Manchester, United Kingdom

  • Greater Manchester Comprehensive Stroke Cntr, Geoffrey Jefferson Brain Rsch Cntr, Salford, United Kingdom

  • Stroke Trials Unit, Mental Health & Clinical Neurosciences, UNIVERSITY OF NOTTINGHAM, Nottingham, United Kingdom

  • Univ of Manchester, Manchester

Locations

  • United States

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Genetic Disorder

  • Central Nervous System (CNS)

Disease

  • Ischemic stroke

Biomarkers

  • Cytochrome P450 2C19

Drug/Treatment

  • dipyridamole

  • Clopidogrel bisulfate

  • Aspirin

  • Albyl-E

Outcome

  • N/A

Study Design

  • Randomized

  • Multinational

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved